SpringerLink
Log in

Azithromycin in cancer treatment: envisioning the probable link of mitochondrial dysfunction and necroptosis

  • Letter to the Editor
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Not applicable.

References

  1. Zhang X, Xu H (2023) Azithromycin inhibits glioblastoma angiogenesis in mice via inducing mitochondrial dysfunction and oxidative stress. Cancer Chemother Pharmacol. https://doi.org/10.1007/s00280-023-04567-y

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hassan SN, Yusoff AAM, Idris Z, Redzwan NM, Ahmad F (2023) A mini-review on anticancer-related properties of azithromycin and its potential activities in overcoming the challenges of glioblastoma. Fundam Clin Pharmacol. https://doi.org/10.1111/fcp.12900

    Article  PubMed  Google Scholar 

  3. **ao Y, **ong T, Meng X, Yu D, **ao Z, Song L (2019) Different influences on mitochondrial function, oxidative stress and cytotoxicity of antibiotics on primary human neuron and cell lines. J Biochem Mol Toxicol 33(4):e22277

    Article  PubMed  Google Scholar 

  4. Wang P, Zheng S-Y, Jiang R-L, Wu H-D, Li Y-A, Lu J-L et al (2023) Necroptosis signaling and mitochondrial dysfunction cross-talking facilitate cell death mediated by chelerythrine in glioma. Free Radic Biol 202:76–96

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank FRGS (203/PPSP/6171203) provided by the Ministry of Higher Education Malaysia, Postgraduate Funding Grant (311/PPSP/4404811), and Universiti Sains Malaysia Fellowship provided by the Universiti Sains Malaysia.

Author information

Authors and Affiliations

  1. Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia

    Siti Nazihahasma Hassan & Farizan Ahmad

  2. Human Genome Center, School of Medical Sciences, Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia

    Farizan Ahmad

  3. Hospital Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia

    Siti Nazihahasma Hassan & Farizan Ahmad

Authors
  1. Siti Nazihahasma Hassan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Farizan Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Farizan Ahmad.

Ethics declarations

Conflict of interest

All authors stated that they have no conflicts of interest regarding the publication of this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hassan, S.N., Ahmad, F. Azithromycin in cancer treatment: envisioning the probable link of mitochondrial dysfunction and necroptosis. Cancer Chemother Pharmacol 93, 639–640 (2024). https://doi.org/10.1007/s00280-023-04617-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-023-04617-5

Keywords

Search

Navigation